Chemoinformaics analysis of TRANS-TRANS-FARNESOL
Molecular Weight | 294.555 | nRot | 9 |
Heavy Atom Molecular Weight | 260.283 | nRig | 3 |
Exact Molecular Weight | 294.238 | nRing | 0 |
Solubility: LogS | -6.754 | nHRing | 0 |
Solubility: LogP | 7.614 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 59.063 |
nHD | 0 | BPOL | 51.285 |
QED | 0.36 |
Synth | 3.029 |
Natural Product Likeliness | 1.411 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.942 |
Pgp-sub | 0.004 |
HIA | 0.003 |
CACO-2 | -4.601 |
MDCK | 0.000011 |
BBB | 0.008 |
PPB | 1.0056 |
VDSS | 7.695 |
FU | 0.00822396 |
CYP1A2-inh | 0.935 |
CYP1A2-sub | 0.391 |
CYP2c19-inh | 0.33 |
CYP2c19-sub | 0.838 |
CYP2c9-inh | 0.747 |
CYP2c9-sub | 0.806 |
CYP2d6-inh | 0.029 |
CYP2d6-sub | 0.177 |
CYP3a4-inh | 0.209 |
CYP3a4-sub | 0.158 |
CL | 5.03 |
T12 | 0.096 |
hERG | 0.02 |
Ames | 0.003 |
ROA | 0.001 |
SkinSen | 0.954 |
Carcinogencity | 0.287 |
EI | 0.967 |
Respiratory | 0.011 |
NR-Aromatase | 0.02 |
Antiviral | Yes |
Prediction | 0.652365 |